Literature DB >> 3340460

Aeromonas-associated gastroenteritis in children.

V H San Joaquin1, D A Pickett.   

Abstract

During a 20-month period 55 strains of Aeromonas species were isolated from 53 children with diarrhea. The isolation rate of 2.5% for Aeromonas compared with the rates of 4.5% for Shigella, 3.3% for Salmonella, 2.7% for Campylobacter and 0.05% for Yersinia. In 45 children Aeromonas was the sole bacterial enteropathogen identified. Aeromonas was also isolated from 2 (0.5%) of 380 asymptomatic children. Despite its known lack of identifiable virulence properties, Aeromonas caviae was the most prevalent species, accounting for 69% of the isolates. None of the A. caviae strains produced cytotoxin by the 51Cr release assay and 12.5% were weakly enterotoxigenic by the infant mouse assay. All of the Aeromonas sobria and 71% of Aeromonas hydrophila were positive for both toxins. Ninety-two percent of the children with Aeromonas-associated diarrhea were younger than 3 years; 84% of the cases were seen between May and October. The majority of the children had an acute onset of watery diarrhea. Fever and vomiting were most commonly associated with the isolation of A. sobria. Eight children had chronic or intermittent diarrhea lasting for weeks to months before consultation; A. caviae was the isolate in all these cases. Several complications possibly related to Aeromonas intestinal infection were observed. These included Gram-negative bacteremia, intussusception, internal hernia strangulation, hemolytic uremic syndrome and failure to thrive in patients with chronic diarrhea.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3340460     DOI: 10.1097/00006454-198801000-00013

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  19 in total

Review 1.  Recent advances in the study of the taxonomy, pathogenicity, and infectious syndromes associated with the genus Aeromonas.

Authors:  J M Janda
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

2.  Aeromonads in acute diarrhoea and asymptomatic infections in Nigerian children.

Authors:  S J Utsalo; F O Eko; O E Antia-Obong; C U Nwaigwe
Journal:  Eur J Epidemiol       Date:  1995-04       Impact factor: 8.082

3.  Extended serogrouping scheme for motile, mesophilic Aeromonas species.

Authors:  L V Thomas; R J Gross; T Cheasty; B Rowe
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

4.  Acute renal failure in an infant associated with cytotoxic Aeromonas sobria isolated from patient's stool and from aquarium water as suspected source of infection.

Authors:  G Filler; J H Ehrich; E Strauch; L Beutin
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Aeromonas spp. and their association with human diarrheal disease.

Authors:  L P Deodhar; K Saraswathi; A Varudkar
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

6.  Cytotoxin and enterotoxin production as factors delineating enteropathogenicity of Aeromonas caviae.

Authors:  H Namdari; E J Bottone
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

7.  Low Prevalence of Aeromonas hydrophilain Infectious Diarrhea Samples of Pediatric Patients in Arak, Iran.

Authors:  Elnaz Abbasi; Behzad Khansari-Nejad; Hamid Abtahi; Majid Akbari; Ehsanollah Ghaznavi-Rad
Journal:  Rep Biochem Mol Biol       Date:  2016-10

8.  Stimulation of specific Aeromonas antibody secretion in rat intestine by gamma-aminobutyric acid.

Authors:  G F Jin; Y S Guo; C W Houston
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

9.  Microbiologic and clinical evidence supporting the role of Aeromonas caviae as a pediatric enteric pathogen.

Authors:  H Namdari; E J Bottone
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

10.  Characterisation of haemolytic activity from Aeromonas caviae.

Authors:  T Karunakaran; B G Devi
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.